국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
LEUCINE ISOLEUCINE LYSINE HYDROCHLORIDE VALINE PHENYLALANINE HISTIDINE THREONINE DL-METHIONINE TRYPTOPHAN, L- ALANINE ARGININE AMINOACETIC ACID PROLINE SERINE TYROSINE SODIUM ACETATE POTASSIUM PHOSPHATE DIBASIC SODIUM CHLORIDE MAGNESIUM CHLORIDE HEXAHYDRATE
Baxter Healthcare Limited
LEUCINE ISOLEUCINE LYSINE HYDROCHLORIDE VALINE PHENYLALANINE HISTIDINE THREONINE DL-METHIONINE TRYPTOPHAN, L- ALANINE
8.5 %w/w
Solution for Infusion
Product subject to prescription which may not be renewed (A)
Authorised
0000-00-00
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0167/091/004 Case No: 2036975 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to BAXTER HEALTHCARE LIMITED CAXTON WAY, THETFORD, NORFOLK IP24 3SE, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product SYNTHAMIN 14, 8.5% W/V AMINO ACID INTRAVENOUS INFUSION, SOLUTION FOR INFUSION The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 03/12/2008. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 03/12/2008_ _CRN 2036975_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% w/v Amino Acid Intravenous Infusion, Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Infusion The product is a clear or slightly coloured sterile aqueous solution. pH 5-7 Tonicity mOsm/l 1160 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Synthamin 14, 8.5% Amino Acid Intravenous Infusion is indicated for the correction of protein depletion and the maintenance of adequate nitrogen and electrolyte balance. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The 전체 문서 읽기